Skip to main content
WAY
NASDAQ Technology

Waystar Reports Strong Q4 & FY25 Results, Provides Positive 2026 Revenue and Profit Guidance

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Health Tech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$22.41
Mkt Cap
$4.287B
52W Low
$21.45
52W High
$48.11
52W Position info
4.5% above low
Off High info
53% below high
Rel. Volume info
2.1× avg
Market data snapshot near publication time

WAY is trading near its 52-week low of $21.45 (4.5% above the low) on elevated volume (2.1× avg).

Summary

Waystar Holding Corp. announced strong fourth quarter and full-year 2025 financial results, with significant revenue growth and healthy profitability, alongside positive guidance for fiscal year 2026.


Key Events · Earnings and Guidance · WAY

  • Strong Q4 2025 Performance

    Reported Q4 2025 revenue of $303.5 million, a 24% increase year-over-year, with net income of $20.0 million and adjusted EBITDA margin of 43%.

  • Solid Full Year 2025 Results

    Achieved full fiscal year 2025 revenue of $1,099.3 million, up 17% year-over-year, with net income of $112.1 million and adjusted EBITDA margin of 42%.

  • Positive 2026 Guidance

    Provided fiscal year 2026 guidance expecting total revenue between $1.274 billion and $1.294 billion, and non-GAAP net income per share between $1.59 and $1.68.

  • Growth Drivers Highlighted

    CEO Matt Hawkins noted record bookings, successful integration of the Iodine acquisition, and accelerating AI-powered innovation as key contributors to growth.


Analysis · WAY · Technology

Waystar Holding Corp. delivered robust financial performance for both the fourth quarter and full fiscal year 2025, exceeding $1 billion in annual revenue. The company's Q4 revenue grew 24% year-over-year, driven by strong subscription and volume-based revenue. Management highlighted record bookings, successful integration of the Iodine acquisition, and accelerated AI-powered innovation as key drivers. The positive 2026 guidance, projecting continued double-digit revenue growth and increased profitability, suggests a confident outlook for the company's healthcare payment software platform. This strong performance and optimistic forecast are particularly notable as the stock is currently trading near its 52-week low, potentially indicating a favorable entry point for investors if the company continues to execute on its growth strategy.

How filings like this one have moved

In the 30 days to Oct 2, 2026, 29.5% of the 1629 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.59%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, WAY was trading at $22.41 on NASDAQ in the Technology sector, with a market capitalization of approximately $4.3B. The 52-week trading range was $21.45 to $48.11. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

WAY - Latest Insights

WAY
Jul 29, 2026, 4:29 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $22.50
Real-time Price: $24.81 info
Change: +$2.31 (+10%) info
Market Cap: $4.757B info
WAY
Jul 29, 2026, 4:04 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $24.52
Real-time Price: $24.81 info
Change: +$0.290 (+1%) info
Market Cap: $4.757B info
WAY
Jul 29, 2026, 4:01 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $22.44
Real-time Price: $24.81 info
Change: +$2.37 (+11%) info
Market Cap: $4.757B info
WAY
May 19, 2026, 8:00 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $18.68
Real-time Price: $24.81 info
Change: +$6.13 (+33%) info
Market Cap: $4.757B info
WAY
Apr 17, 2026, 4:32 PM EDT
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $25.87
Real-time Price: $24.81 info
Change: -$1.06 (-4%) info
Market Cap: $4.757B info